Stockreport

ViaCyte's Stem Cell-Derived Treatment For Type 1 Diabetes Shows Promising Results In Two Published Studies [TheStreet.com]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF SAN DIEGO, Dec. 2, 2021 /PRNewswire/ --, a clinical-stage regenerative medicine company focused on developing novel cell replacement therapies to address diseases with s [Read more]